Search Results

Olympus Corporation of the Americas, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, is now partnering with the American Lung Association to educate lung cancer patients about the care pathway for diagnosing and staging lung nodules.

Lung cancer remains the leading cause of cancer deaths in the United States, with someone diagnosed approximately every two minutes.

The American Lung Association Research Institute announced it awarded $13.6 million in research grants to fund 129 innovative projects to advance today’s science to end the burden of lung disease tomorrow.

bioAffinity Technologies, Inc. today announced the expansion of its partnership with the American Cancer Society (ACS) to raise funding for ACS’ Lung Quality Improvement (QI) initiative to increase the rate of lung cancer screening.

Aerami Therapeutics announced the presentation of new lung deposition modeling data for AER-901 at the American Thoracic Society 2024 International Conference being held May 17-22, 2024, in San Diego, California.

The American Lung Association Research Institute announced a three-year, $500,000 grant to Texas Biomedical Research Institute to help accelerate its efforts to develop a universal flu vaccine.

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa) today announced its sponsorship of the American Heart Association’s new Addressing Recurrent Pericarditis initiative, a multi-faceted effort to improve quality of care through identification, dissemination, and implementation of best practices for the diagnosis and management of recurrent pericarditis.

MannKind Corporation announced that the 17-week endpoint results from the INHALE-3 study will be presented during a 90-minute symposium and livestream on Saturday, June 22, at the American Diabetes Association’s 84th Scientific Sessions.